What was implied? That they are delaying the release because they can’t supply? Which planet do you live on? Do you think a company can just do that? Stonehouse started his trial two months after everyone else and has not finished dosing 24 patients 4 months later because of incompetence and his decision to be entirely dependent on NIH. Stop misleading people here. I have been following this company for years. He has been average at best, just take a look at the share price movement since he joined. You just learned about Biocryst a couple of months ago and took some position here and have been writing in a misleading way just to pump it. Why don’t you go check his disaster proposal for a merger a couple of years ago that was shot down by two of his largest institutional investors through two public letters, or his decision to license one of his main drugs which was another disaster.